Anagram Therapeutics
About Anagram Therapeutics
Anagram Therapeutics is a clinical stage biopharmaceutical company focused on developing novel, orally delivered enzyme therapeutics. These therapies aim to treat serious diseases caused by malabsorption syndromes and nutrient deficiencies. The company is dedicated to advancing enzyme replacement therapies that are currently entering clinical trials, particularly for conditions such as cystic fibrosis. Anagram Therapeutics leverages its expertise in biotechnology to create innovative solutions for unmet medical needs.
Company Facts
- Legal name: Anagram Therapeutics, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Website: anagramtx.com
- Phone: +1 617 466 3111
Social Profiles
Canonical: https://fsome.com/organization/anagram-therapeutics-8450719 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.